When reason does not win the day, use money! And that is just what Congress appears to be doing by keeping FDA from spending any appropriated funds on their controversial labeling rule that would permit generic manufacturers to revise their labeling to include new warnings. Our friends at RAPS had a nice article on this development late yesterday (see here) .
Suffice it to say – we have blogged heavily on this subject and believe that it is probably the worst idea since perhaps the beginning of time. Let’s hope FDA gets the message on this one.
